Skip to main content
. 2022 Jun 30;10(4):75. doi: 10.3390/pharmacy10040075

Table 1.

Socio-demographic and clinical characteristics of the lung transplant patient population included in this analysis (n = 53).

Characteristic n (%)
Sex Male 33 −62
Age (years) <40 15 −28
40 ≤ Age ≤ 60 15 −28
>60 23 −43
Marital Status Married 26 −49
Single 18 −34
Divorced 9 −17
Occupational Unemployed 19 −36
Employed/Student 16 −30
Retired 18 −34
ICT accessibility Possession of a mobile phone 50 −94
Package to send free SMS 37 −70
Comfortable with SMS 41 −77
Internet access at home 46 −87
Comfortable with email 35 −66
Comfortable with internet 39 −74
Indication of LT COPD/Emphysema/bronchiectasis 28 −53
Cystic fibrosis 14 −26
Pulmonary fibrosis/PH 11 −21
Post-transplantation time <1 year 12 −23
≥1 year 41 −77
Immunosuppressive therapy regimen tacrolimus + MMF + corticosteroids 26 −49
tacrolimus + MMF + everolimus + corticosteroids 18 −34
tacrolimus + AZA + corticosteroids 3 −6
tacrolimus + everolimus + corticosteroids 3 −6
tacrolimus + AZA + everolimus + corticosteroids 1 −2
tacrolimus + MMF + everolimus 1 −2
everolimus + corticosteroids 1 −2
Therapeutic Drug Monitoring For 1 immunosuppressive drug 30 −57
For 2 immunosuppressive drugs 23 −43